Es Ghc Nph Bbi Choice

---
name: es-ghc-nph-bbi-choice
description: Select either NPH-based insulin regimen or basal bolus insulin regimen for glycemic management in patients receiving glucocorticoids. Triggered by clinician questions such as "Which insulin regimen should we use for steroid-induced hyperglycemia?"
---

# Choose between NPH-based or basal bolus insulin for glucocorticoid-associated hyperglycemia

## STEP 1 — Gather Information
Collect glucocorticoid dose and schedule, current hyperglycemia status, existing insulin therapy, nutritional status (regular meals vs NPO/TPN/enteral), and patient/family ability to manage multiple daily injections. Proceed to assess eligibility for NPH-based or BBI regimens.

## STEP 2 — Rule In / Rule Out
Rule out NPH-based or BBI regimens if the patient is NPO, receiving total parenteral nutrition, or enteral feeding (evidence limited to regular meals); if ruled out, consider alternative insulin strategies (e.g., correctional insulin) per other guideline sections. If patient is eating regular meals, continue to classification; otherwise, pursue alternative glycemic management.

## STEP 3 — Classify or Stratify
Classify based on current insulin regimen: if already on basal bolus insulin, consider adding NPH to the existing regimen; if insulin-naïve or on basal-only, stratify by preference for once-daily dosing versus multiple daily injections and nursing resources. Select candidate regimen (NPH-based or BBI) for further decision.

## STEP 4 — Decide
Decide on NPH-based regimen if once-daily dosing aligns with patient lifestyle and glucocorticoid pharmacokinetics (e.g., morning prednisone); otherwise choose basal bolus insulin with prandial coverage matched to meals. Implement chosen insulin regimen with orders for dose and monitoring.

## Clinical Guardrails / Mimics / Pitfalls
Monitor point-of-care glucose before meals and at bedtime; adjust insulin doses when glucocorticoids are tapered or stopped to prevent hypoglycemia. Avoid NPH-based regimens in patients with unpredictable meal intake or on tube feeds. Do not rely solely on NPH without prandial insulin if carbohydrate intake varies significantly.

## Concrete Clinical Example
A 68-year-old woman with rheumatoid arthritis receives prednisone 20 mg daily, develops hyperglycemia (glucose 180-250 mg/dL), eats regular meals, and is insulin-naïve. The team chooses an NPH-based regimen: NPH 10 units subcutaneously each morning before breakfast, with rapid-acting insulin before meals as needed based on glucose.

**Source:** Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings: An Endocrine Society Clinical Practice Guideline, Endocrine Society, 2022, DOI:10.1210/clinem/dgac278